# Nuclide record radioimmunotherapy (technology). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/technologies/radioimmunotherapy/>
  a schema:MedicalTherapy ;
  nuclide:kind "technology" ;
  schema:identifier "radioimmunotherapy" ;
  schema:name "Radio-antibody & radio-ADC"@en ;
  schema:description "Attaching a radioactive atom to an antibody, so an ADC's targeting is used to deliver radiation instead of chemotherapy."@en ;
  schema:url <https://nuclide.cc/technologies/radioimmunotherapy/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Radioimmunotherapy> ;
  owl:sameAs <http://www.wikidata.org/entity/Q2126427> ;
  schema:citation <https://en.wikipedia.org/wiki/Radioimmunotherapy> ;
  nuclide:status "phase-2" ;
  nuclide:tag "frontier" ;
  nuclide:related <https://nuclide.cc/ideas/idea-alpha-after-adc/>, <https://nuclide.cc/isotopes/lu-177/>, <https://nuclide.cc/isotopes/ac-225/>, <https://nuclide.cc/isotopes/i-131/>, <https://nuclide.cc/isotopes/y-90/> ;
  nuclide:technologies <https://nuclide.cc/technologies/targeted-alpha-therapy/> ;
  nuclide:targets <https://nuclide.cc/targets/psma/>, <https://nuclide.cc/targets/dll3/>, <https://nuclide.cc/targets/her2/> ;
  nuclide:companies <https://nuclide.cc/companies/abdera-therapeutics/>, <https://nuclide.cc/companies/actinium-pharmaceuticals/>, <https://nuclide.cc/companies/convergent-therapeutics/> ;
  nuclide:journals <https://nuclide.cc/journals/cancer-biotherapy-and-radiopharmaceuticals/> ;
  nuclide:dependsOn <https://nuclide.cc/technologies/therapy-isotope-supply-chain/> .